long covid

  1. SNT Gatchaman

    UCSF Magazine: What’s New in the Search for a Long COVID Cure?

    What’s New in the Search for a Long COVID Cure? Effective therapies that target the condition’s root causes could be a few years away. Interviewing Michael Peluso, most recently author of Reduced exercise capacity, chronotropic incompetence, and early systemic inflammation in cardiopulmonary...
  2. SNT Gatchaman

    Comorbidity genetic risk and pathways impact SARS-CoV-2 infection outcomes, 2023, Jaros et al.

    Comorbidity genetic risk and pathways impact SARS-CoV-2 infection outcomes Jaros, Rachel K.; Fadason, Tayaza; Cameron-Smith, David; Golovina, Evgeniia; O’Sullivan, Justin M. Understanding the genetic risk and mechanisms through which SARS-CoV-2 infection outcomes and comorbidities interact to...
  3. SNT Gatchaman

    Large scale phenotyping of long COVID inflammation reveals mechanistic subtypes of disease, 2023, Liew et al.

    Large scale phenotyping of long COVID inflammation reveals mechanistic subtypes of disease One in ten SARS-CoV-2 infections result in prolonged symptoms termed ‘long COVID’, yet disease phenotypes and mechanisms are poorly understood. We studied the blood proteome of 719 adults, grouped by...
  4. SNT Gatchaman

    Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for AF and sudden cardiac death, 2023

    Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors Fiedler, Lukas; Motloch, Lukas J.; Dieplinger, Anna-Maria; Jirak, Peter...
  5. Hutan

    Protocol Phase III Clinical Trial on the Efficacy and Safety of Meplazumab ... in the Treatment of Post-covid-19, 2023

    The actual study start date was March 2023, the estimated primary end date was 1 June 2023 and the estimated study completion date is 1 October 2023. Clinical Trials link: https://clinicaltrials.gov/ct2/show/NCT05813587?term=Meplazumab&draw=2&rank=8 Randomized, double-blind...
  6. SNT Gatchaman

    Long COVID: Costs for the German economy and health care and pension system, 2023, Gandjour

    Long COVID: Costs for the German economy and health care and pension system Gandjour, Afschin Background Patients with acute COVID-19 can develop persistent symptoms (long/post COVID-19 syndrome). This study aimed to project the economic, health care, and pension costs due to long/post-COVID-19...
  7. V

    Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective 2020 Gupta et al

    This review highlights the well-known immunomodulatory effect of mesenchymal stem cells (MSCs) as an alternative therapy for inflammatory and autoimmune diseases. Recent studies have shown that MSC-derived extracellular vesicles (EVs), including exosomes, exhibit similar therapeutic effects. The...
  8. SNT Gatchaman

    “We’re drowning and we’re alone”:a qualitative study of the lived experience of people experiencing persistent post-COVID-19 symptoms,2023, Goodridge+

    “We’re drowning and we’re alone”: a qualitative study of the lived experience of people experiencing persistent post-COVID-19 symptoms Donna Goodridge; Thomas N. Lowe; Shuang Cai; Flinn N. Herriot; Rachel V. Silverberg; Michael Heynen; Kelly C. Hall; Jaimie Peters; Scotty Butcher; Taofiq...
  9. SNT Gatchaman

    Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months, 2023, Santopaolo et al.

    Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months Marianna Santopaolo; Michaela Gregorova; Fergus Hamilton; David Arnold; Anna Long; Aurora Lacey; Alice Halliday; Holly Baum; Kristy Hamilton; Rachel Milligan; Elizabeth Oliver; Olivia...
  10. SNT Gatchaman

    The effect of hyperbaric oxygen therapy on myocardial function in post-COVID-19 syndrome patients: a randomized controlled trial, 2023, Leitman et al.

    The effect of hyperbaric oxygen therapy on myocardial function in post-COVID-19 syndrome patients: a randomized controlled trial Leitman, Marina; Fuchs, Shmuel; Tyomkin, Vladimir; Hadanny, Amir; Zilberman-Itskovich, Shani; Efrati, Shai Post-COVID-19 condition refers to a range of persisting...
  11. SNT Gatchaman

    Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function, 2023, Iosef et al

    Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function Iosef, Cristiana; Knauer, Michael J.; Nicholson, Michael; Van Nynatten, Logan R.; Cepinskas, Gediminas; Draghici, Sorin; Han, Victor K. M.; Fraser, Douglas D. Aims...
  12. SNT Gatchaman

    Persistent serum protein signatures define an inflammatory subcategory of long COVID, 2023, Talla et al.

    Persistent serum protein signatures define an inflammatory subcategory of long COVID Talla, Aarthi; Vasaikar, Suhas V.; Szeto, Gregory Lee; Lemos, Maria P.; Czartoski, Julie L.; MacMillan, Hugh; Moodie, Zoe; Cohen, Kristen W.; Fleming, Lamar B.; Thomson, Zachary; Okada, Lauren; Becker, Lynne A...
  13. Sly Saint

    USA: “Movie About M.E." and "Banner for Awareness" (formerly "One Name Campaign")

    Date & Time : Fri, Jun 16 5:00 PM - 7:00 PM **Events may have been canceled or postponed. Please contact the venue to confirm the event. https://www.independent.com/events/movie-screening-movie-about-m-e-long-covid-event/
  14. Sly Saint

    Review A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action..., 2023, Rahmati et al

    A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences Abstract Long-term sequelae conditions of COVID-19 at least 2-year following SARS-CoV-2 infection are unclear and...
  15. SNT Gatchaman

    Impact of fatigue as the primary determinant of functional limitations among patients with post-COVD-19 syndrome, 2023, Walker et al

    Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional observational study Sarah Walker; Henry Goodfellow; Patra Pookarnjanamorakot; Elizabeth Murray; Julia Bindman; Ann Blandford; Katherine Bradbury; Belinda Cooper...
  16. SNT Gatchaman

    Forbes: Dutch Survey Data Shows Significant Increase In Memory And Concentration Problems Among Adults Since Start Of Covid-19 Pandemic

    Not sure how the following paragraph even made it in when we're talking about a 31% increase in GP visits for this in 25-44 year olds... Back to reality... Article
  17. Sly Saint

    Tryptophan catabolites, inflammation, and insulin resistance as determinants of CFS and affective symptoms in long COVID, 2023, Al-Hakeim, Maes et al

    Critical COVID-19 disease is accompanied by depletion of plasma tryptophan (TRY) and increases in indoleamine-dioxygenase (IDO)-stimulated production of neuroactive tryptophan catabolites (TRYCATs), including kynurenine (KYN). The TRYCAT pathway has not been studied extensively in association...
  18. John Mac

    Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms 2023 Braga et al

    Key Points Question Is translocator protein distribution volume (TSPO VT), an index of gliosis (an inflammatory change), measured by positron emission tomography, elevated in the brain after acute COVID-19 infection with sequelae of depressive and cognitive symptoms? Findings In this...
  19. SNT Gatchaman

    Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study, 2023, Ballouz et al.

    Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study Tala Ballouz; Dominik Menges; Alexia Anagnostopoulos; Anja Domenghino; Hélène E Aschmann; Anja Frei; Jan S Fehr; Milo A Puhan Objective To evaluate longer term symptoms and...
  20. SNT Gatchaman

    Long-Term Adverse Effects of Mild COVID-19 Disease on Arterial Stiffness, and Systemic and Central Hemodynamics: A Pre-Post Study, 2023, Podrug et al.

    Long-Term Adverse Effects of Mild COVID-19 Disease on Arterial Stiffness, and Systemic and Central Hemodynamics: A Pre-Post Study Podrug, Mario; Koren, Pjero; Dražić Maras, Edita; Podrug, Josip; Čulić, Viktor; Perissiou, Maria; Bruno, Rosa Maria; Mudnić, Ivana; Boban, Mladen; Jerončić, Ana...
Back
Top Bottom